Hemostatic absorbable material
Vietnam·Risk Class TTBYT Loại D·SURGICEL Absorbable Hemostat Original·Ethicon, LLC·Registered Aug 30, 2024- Analysis ID
- 2402329ĐKLH/BYT-HTTB
- Submission ID
- 000.00.04.G18-221201-0008
- Product Type
- SURGICEL Absorbable Hemostat Original
- Product Code
- 1953S
- Manufacturer
- Ethicon, LLC
- Manufacturer Country
- UNITED STATES
- Product Owner
- Ethicon SARL
- Authorized Representative
- CÔNG TY TNHH JOHNSON & JOHNSON (VIỆT NAM)
- Intended Use
- -Indications for Surgery: Surgicel (recombinant oxidized cellulose, U.S.P.) is used as an adjunct to surgical procedures to control bleeding in small arteries, veins and capillaries when the ligation method or other conventional control methods are not feasible or effective. Surgicel ORIGINAL, Surgicel Fibrillar, and Surgicel NU-KNIT can be cut to the desired size for endoscopic procedures. -Indications for Dentistry: Surgicel (recombinant oxidized cellulose, U.S.P.) is indicated to assist in controlling bleeding during tooth extraction and oral surgery. The material can also be used to control bleeding after tooth extraction, periodontal surgery, gum bleeding, extraction of impacted teeth, biopsies and other procedures in the mouth.
- Registration Date
- Aug 30, 2024
Companies providing products similar to "Hemostatic absorbable material"
Recently registered similar products
Access comprehensive regulatory information for Hemostatic absorbable material in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402329ĐKLH/BYT-HTTB and manufactured by Ethicon, LLC. The authorized representative in Vietnam is CÔNG TY TNHH JOHNSON & JOHNSON (VIỆT NAM).
This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Medprin Biotech GmbH, Ethicon, LLC, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.